Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Boehringer Ingelheim
Mallinckrodt
Colorcon
Harvard Business School

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Volasertib


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Volasertib?

Volasertib is an investigational drug.

There have been 25 clinical trials for Volasertib. The most recent clinical trial was a Phase 3 trial, which was initiated on January 29th 2013.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are Boehringer Ingelheim, National Comprehensive Cancer Network, and Anne Beaven, MD.

There are two hundred and two US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Volasertib
TitleSponsorPhase
A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid LeukemiaUniversity of AlbertaPhase 1
A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy FailedBoehringer IngelheimPhase 1
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCLBoehringer IngelheimPhase 1

See all Volasertib clinical trials

Clinical Trial Summary for Volasertib

Top disease conditions for Volasertib
Top clinical trial sponsors for Volasertib

See all Volasertib clinical trials

US Patents for Volasertib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Volasertib ⤷  Try it Free Peptides and combination of peptides for use in immunotherapy against various tumors IMMATICS BIOTECHNOLOGY GMBH (Tuebingen, DE) ⤷  Try it Free
Volasertib ⤷  Try it Free Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ⤷  Try it Free
Volasertib ⤷  Try it Free Peptides and combination of peptides for use in immunotherapy against various tumors IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE) ⤷  Try it Free
Volasertib ⤷  Try it Free .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA) ⤷  Try it Free
Volasertib ⤷  Try it Free Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Volasertib

Drugname Country Document Number Estimated Expiration Related US Patent
Volasertib Argentina AR104113 2035-03-27 ⤷  Try it Free
Volasertib Argentina AR112781 2035-03-27 ⤷  Try it Free
Volasertib Australia AU2016239920 2035-03-27 ⤷  Try it Free
Volasertib Australia AU2018232952 2035-03-27 ⤷  Try it Free
Volasertib Australia AU2019202561 2035-03-27 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Boehringer Ingelheim
Mallinckrodt
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.